Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC

NCT00226590 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Gemcitabine
DRUG: Carboplatin
DRUG: Paclitaxel
PROCEDURE: Radiation

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]